Jennerex appoints Dr James Burke VP of clinical research
This article was originally published in Scrip
Executive Summary
Jennerex, a San Francisco-based cancer biotherapeutics company, has appointed Dr James Burke to the newly-created position of vice-president of clinical research; he will be responsible for global clinical research activities related to Jennerex' pipeline. Dr Burke, who has 20 years' experience in the clinical science of genetic and immunotherapy, has been working with Jennerex in an advisory capacity as a clinical advisor for more than a year.
You may also be interested in...
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.